Citations

Clear

6 citation(s) found for "Su, Mingming".

Quantification of porcine lower thoracic spinal cord morphology with intact dura mater using high‐resolution μCT
Chin, J. , Settell, Megan L. , Brucker-Hahn, Meagan , Lust, Daniel, Zhang, Jichu , Upadhye, Aniruddha , Deshmukh, Ashlesha , Ludwig, Kip A. , Lavrov, Igor , Crofton, Andrew , Lempka, Scott F. , Chin, Justin , Brucker-Hahn, Meagan K , Upadhye, Aniruddha R , Deshmukh, Ashlesha , Ludwig, Kip A , Lavrov, Igor , Crofton, Andrew R , Lempka, Scott F , Zhang, Mingming , Shoffstall, Andrew J , Knudsen, Bruce E. , Shoffstall, Andrew J.

Mayo Clinic

Journal of Neuroimaging | October 11, 2024 | Volume: 34 | Issue: 6 | Pages: 646-663

10.1111/jon.13239 | PMID 39390716 Get It

AbstractBackground and PurposeSpinal cord stimulation (SCS) is approved by the Food and Drug Administration for treating chronic intractable pain in the back, trunk, or limbs through stimulation of the dorsal column. Numerous studies have used swine as an analog of the human spinal cord to better understand SCS and further improve its efficacy. We performed high‐resolution imaging of the porcine spinal cord with intact dura mater using micro‐computed tomography (μCT) to construct detailed 3‐dimensional (3D) visualizations of the spinal cord and characterize the morphology of the dorsal and ventral rootlets.MethodsWe obtained spinal cords from Yorkshire/Landrace crossbred swine (N = 7), stained samples with osmium tetroxide, and performed μCT imaging of the T12‐T15 levels at isotropic voxel resolutions ranging from 3.3 to 50 μm. We measured the anatomical morphology using the 3D volumes and compared our results to measurements previously collected from swine and human spinal cords via microdissection techniques in prior literature.ResultsWhile the porcine thoracic‐lumbar spinal cord is a popular model for SCS, we highlight multiple notable differences compared to previously published T8‐T12 human measurements including rootlet counts (porcine dorsal/ventral: 12.2 ± 2.6, 26.6 ± 3.4; human dorsal/ventral: 5.3 ± 1.3, 4.4 ± 2.4), rootlet angles (porcine ventral‐rostral: 161 ± 1°, ventral‐caudal: 155 ± 6°, dorsal‐rostral: 148 ± 9°, dorsal‐caudal: 142 ± 6°; human ventral‐rostral: 170 ± 3°, ventral‐caudal: 22 ± 10°, dorsal‐rostral: 171 ± 3°, dorsal‐caudal: 15 ± 7°), and the presence and count of dorsal rootlet bundles.ConclusionsDetailed measurements and highlighted differences between human and porcine spinal cords can inform variations in modeling and electrophysiological experiments between the two species. In contrast to other approaches for measuring the spinal cord and rootlet morphology, our method keeps the dura intact, reducing potential artifacts from dissection.
Beta-Blocker Use and Outcomes in Patients with Heart Failure and Mildly Reduced and Preserved Ejection Fraction
Henderson, Alasdair D , Shen, Li , Campbell, Ross T. , Boer, Rudolf A. de , Lam, Carolyn S.P., Maggioni, Aldo P. , Martínez, Felipe A. , Redfield, Margaret M. , Rouleau, Jean L. , Veldhuisen, Dirk Jan van, Zannad, Faı̈ez , Solomon, Scott, de Boer, Rudolf A , Maggioni, Aldo P , Matsumoto, Shingo , Kondo, Toru , Yang, Mingming , Anand, Inder S. , Desai, Akshay S , Lam, Carolyn S.P. , Packer, Milton , Veldhuisen, Dirk J. van , Vaduganathan, Muthiah , Zile, Michael R. , Jhund, Pardeep S. , McMurray, John J.V.

Mayo Clinic

European Journal of Heart Failure | August 31, 2024 | Volume: 27 | Issue: 1 | Pages: 124-139

10.1002/ejhf.3383 | PMID 39215677 Get It

ABSTRACT Aims In the absence of randomized trial evidence, we performed a large observational analysis of the association between beta-blocker (BB) use and clinical outcomes in patients with heart failure (HF) and mildly reduced (HFmrEF) and preserved ejection fraction (HFpEF). Methods and results We pooled individual patient data from four large HFmrEF/HFpEF trials (I-Preserve, TOPCAT, PARAGON-HF, and DELIVER). The primary outcome was the composite of cardiovascular death or HF hospitalization. Among the 16 951 patients included, the mean left ventricular ejection fraction (LVEF) was 56.8%, and 13 400 (79.1%) had HFpEF (LVEF ≥50%). Overall, 12 812 patients (75.6%) received a BB. The median bisoprolol-equivalent dose of BB was 5.0 (Q1–Q3: 2.5–5.0) mg with BB continuation rates of 93.1% at 2 years (in survivors). The unadjusted hazard ratio (HR) for the primary outcome did not differ between BB users and non-users (HR 0.98, 95% confidence interval [CI] 0.91–1.05), but the adjusted HR was lower in BB users than non-users (0.81, 95% CI 0.74–0.88), and this association was maintained across LVEF (pinteraction = 0.88). In subgroup analyses, the adjusted risk of the primary outcome was similar in BB users and non-users with or without a history of myocardial infarction, hypertension, or a baseline heart rate <70 bpm. By contrast, a better outcome with BB use was seen in patients with atrial fibrillation compared to those without atrial fibrillation (pintreraction = 0.02). Conclusions In this observational analysis of non-randomized BB treatment, there was no suggestion that BB use was associated with worse HF outcomes in HFmrEF/HFpEF, even after extensive adjustment for other prognostic variables.
The 2022 FASEB Virtual Catalyst Conference on the Cardiac Interatrial Septum and Stroke Risk, December 7, 2022
Schilling, Jonathan , Lin, Jeannette , Mankad, Sunil , Krishnam, Mayil S. , Ning, MingMing , Patel, Pranav M. , Kim, Chi Kyung , Kapoor, R , Tullio, Marco R. Di , Jung, Jin‐Man , Kim, Jin Kyung , Fisher, Mark , Lin, Jeannette P , Mankad, Sunil V , Kapoor, Ruchi , Di Tullio, Marco R , Jung, Jinman , Fisher, Mark J

Mayo Clinic

The FASEB Journal | August 22, 2023 | Volume: 37 | Issue: 9 | Pages: No page available

10.1096/fj.202300897 | PMID 37606555 Get It

Abstract There is emerging evidence that the cardiac interatrial septum has an important role as a thromboembolic source for ischemic strokes. There is little consensus on treatment of patients with different cardiac interatrial morphologies or pathologies who have had stroke. In this paper, we summarize the important background, diagnostic, and treatment considerations for this patient population as presented during the Federation of American Societies for Experimental Biology (FASEB) Virtual Catalytic Conference on the Cardiac Interatrial Septum and Stroke Risk, held on December 7, 2022. During this conference, many aspects of the cardiac interatrial septum were discussed. Among these were the embryogenesis of the interatrial septum and development of anatomic variants such as patent foramen ovale and left atrial septal pouch. Also addressed were various mechanisms of injury such as shunting physiologies and the consequences that can result from anatomic variants, as well as imaging considerations in echocardiography, computed tomography, and magnetic resonance imaging. Treatment options including anticoagulation and closure were addressed, as well as an in‐depth discussion on whether the left atrial septal pouch is a stroke risk factor. These issues were discussed and debated by multiple experts from neurology, cardiology, and radiology.
P4‐031: Integrative Network Analysis of Multiple Alzheimer's Disease Rnaseq Studies From the Accelerating Medicine Partnership‐Alzheimer's Disease Consortium
Zhang, Bin , Komashko, Vitalina, Mostafavi, Sara , Funk, Cory C. , Allen, Mariet , Amberkar, Sandeep , Hide, Winston, Schadt, Eric , Jager, Philip L. De , Ertekin‐Taner, Nilüfer , Logsdon, Ben , Chen, Mingming , Perumal, Thanneer Malai , Hide, Winston, Friend, Stephen , Bennett, David A. , Price, Nathan D. , Mangravite, Lara M.

Mayo Clinic

Alzheimer's & Dementia | October 17, 2016 | Volume: 12 | Issue: 7S_Part_21 | Pages: No page available

10.1016/j.jalz.2016.06.2120 Get It

Distinct Metabolic Signature of Human Bladder Cancer Cells Carrying an Impaired Fanconi Anemia Tumor-Suppressor Signaling Pathway
Panneerselvam, Jayabal, Xie, Guoxiang , Che, Raymond , Jia, Wei , Fei, Peiwen, Su, Mingming , Zhang, Jun , Jia, Wei Ping

Mayo Clinic

Journal of Proteome Research | March 9, 2016 | Volume: 15 | Issue: 4 | Pages: 1333-1341

10.1021/acs.jproteome.6b00076 | PMID 26956768 Get It

Hirsutinolide Series Inhibit Stat3 Activity, Alter GCN1, MAP1B, Hsp105, G6PD, Vimentin, TrxR1, and Importin α-2 Expression, and Induce Antitumor Effects against Human Glioma
Miklóssy, Gabriella, Zhang, Mingming , Chen, Chih-Hong, Hilliard, Tyvette S. , Paladino, David, Choi, Justin Chin-Bong , Kawakami, Joel K., Wongwiwatthananukit, Supakit , Chen, Yuan , Sun, Dianqing , Chang, Leng Chee , Turkson, James , Youn, Ui Joung , Yue, Peibin , Li, Yifei , Sarkaria, Jann N.

Mayo Clinic

Journal of Medicinal Chemistry | September 2, 2015 | Volume: 58 | Issue: 19 | Pages: 7734-7748

10.1021/acs.jmedchem.5b00686 | PMID 26331426 Get It